Ocular Melanoma Clinical Trials

Interested in ocular melanoma clinical trials? Click here for helpful resources.

Ocular Melanoma Clinical Trials Search

ClinicalTrials.gov Database

"ClinicalTrials.gov, a [free] resource provided by the U.S. National Library of Medicine, is a registry and results information database of clinical research studies sponsored or funded by a broad range of public and private organizations around the world."

"Information is provided by study sponsors and investigators, and they are responsible for ensuring that the studies follow all applicable laws and regulations."

Click Here to Search for Ocular Melanoma Trials at ClinicalTrials.gov

Assistance When Using ClinicalTrials.gov

General Information for Using ClinicalTrials.gov

Filling Out the Search Fields and Understanding Results:

Instructions from ClinicalTrials.gov on "how to use search," "how to use advanced search," and "how to modify a search."
Glossary of Common Terms "will help you understand words and phrases frequently used [in search fields and results] on ClinicalTrials.gov."

EyeMelanoma.org Tips When Searching ClinicalTrials.gov:

Search results will differ depending on which term is placed in the "condition/disease" field. To get started:

Use Ocular Melanoma to broadly describe the tumor. If in the uvea: Be sure to use Uveal Melanoma (the most results in the database), and try again with the specific part of the uvea — Choroidal Melanoma, Iris Melanoma, or Ciliary Body Melanoma. If in the conjunctiva: Use Conjunctival Melanoma.

Support from National Cancer Institute

General Information for Using ClinicalTrials.gov

Phone, Online Chat, and Email Support During Search:

"NCI's Cancer Information Service provides accurate, up-to-date, and reliable information that is easy to understand and free of charge. Our trained information specialists provide personalized responses to a range of cancer questions, including tailored clinical trials searches." [Note: ClinicalTrials.gov includes in its database all of the NCI-supported clinical trials, which are those sponsored or otherwise financially supported by the National Cancer Institute.]

1-800-422-6237 [toll free], Monday through Friday 9 a.m. – 9 p.m. Eastern Standard Time. Both phone support and one-on-one online chats are available during these hours. This service is also available in Spanish.

Get Contact Information

Important Info About Participating in Any Clinical Trial

Clinical Trials Guide for Patients

Deciding Whether to Be Part of a Clinical Trial

From National Cancer Institute

Topics include:

"What Are Clinical Trials?"
"Paying for Clinical Trials"
"Patient Safety"
"Questions to Ask Your Doctor about Clinical Trials"

(Be sure to click on the "+" sign next to each topic in the left-hand column of the guide for additional information.)

(Also available in Spanish.)

Access This Guide

Deciding Whether to Be Part of a Clinical Trial

From American Cancer Society

ACS provides a printable list of "Questions to Ask Before Joining a Clinical Trial" and discusses "Risks vs. Benefits" and "Common Concerns About Clinical Trials."

Learn More

Learning About Research Participation

Deciding Whether to Be Part of a Clinical Trial

Learning About Research Participation

From U.S. Department of Health and Human Services' Office for Human Research Protections

Resources include "Questions to Ask About Volunteering for a Research Study," "Regulations to Protect Research Volunteers," and "Short Videos About Participating in Human Research."

(Also available in Spanish.)

Learn More

Expanded Access (Compassionate Use)

U.S. Food & Drug Administration's Expanded Access Process

How to Find "Expanded Access Availability" on ClinicalTrials.gov

"Sometimes called 'compassionate use,' expanded access is a potential pathway for a patient with a serious or life-threatening disease or condition to try an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when there are no comparable or satisfactory therapies available. [...] There are times when it is not possible for a patient to be a part of a clinical trial. In those circumstances, expanded access may be the only way for a patient to receive an investigational medical product. The U.S. Food and Drug Administration is committed to increasing awareness about the expanded access process."

Learn More

How to Find "Expanded Access Availability" on ClinicalTrials.gov

By clicking on the "advanced search" link on the ClinicalTrials.gov main page, you will find both settings that are needed in the very first section of the Advanced Search page:

Fill in the "condition/disease" field.
Click on the "Expanded Access: Available" checkbox in the "status" list.

For example, advanced search results on 11/17/21 — using "uveal melanoma" in the "condition/disease" field — showed the following as available for expanded access use:

"Managed Access Program Supporting Patient Access to Tebentafusp" (Sponsor: Immunocore)
"An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma" (Sponsor: Delcath Systems)

OCULAR MELANOMA CLINICAL TRIALS